Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Yusuke Okuma

A case of polymyositis in a chronic hepatitis C patient treated with peg-interferon-alpha 2b and ribavirin therapy

scientific article published on 6 August 2009

A case of successful preoperative chemotherapy with cisplatin and irinotecan followed by curative-intent surgery for locally advanced thymic carcinoma

scientific article published on 04 July 2012

A multi-institutional study of clinicopathological features and molecular epidemiology of epidermal growth factor receptor mutations in lung cancer patients living with human immunodeficiency virus infection

scientific article published on 24 March 2015

A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report

scientific article published on 12 October 2016

A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer.

scientific article published on 23 June 2016

A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancer

scientific article

A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911.

scientific article published on 11 July 2015

A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer

scientific article published on 16 April 2019

Acute adverse effects of radiation therapy on HIV-positive patients in Japan: study of 31 cases at Tokyo Metropolitan Komagome Hospital

scientific article published on 23 October 2010

Alectinib for choroidal metastasis in a patient with crizotinib-resistant ALK rearranged positive non-small cell lung cancer

scientific article published on 3 June 2015

Association Between Clinicopathological Features and Programmed Death Ligand 1 Expression in Non-small Cell Lung Cancer

scientific article published in February 2018

Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case report

scientific article published on 14 September 2017

Cellulitis-like symptoms manifested by bone metastasis of lung cancer in a patient living with human immunodeficiency virus.

scientific article published on 24 September 2015

Ceritinib for an anaplastic lymphoma kinase rearrangement-positive patient previously treated with alectinib with poor performance status

Chemoradiotherapy for unresectable cases of thymic epithelial tumors: a retrospective study.

scientific article published in October 2017

Chemotherapy for thymic carcinoma

scientific article published on 01 May 2012

Choroidal metastasis in a patient with small cell lung cancer discovered during treatment with chemotherapy

scientific article published on 05 December 2009

Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: evaluation of efficacy and toxicity

scientific article published on 12 June 2011

Clinical characteristics of Japanese lung cancer patients with human immunodeficiency virus infection.

scientific article published on 16 September 2011

Clinical outcome of thymic lymphoepithelioma-like carcinoma: Case report of a 14-year-old male

scientific article

Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center

scientific article

Concomitant chemoradiotherapy and antiretroviral therapy for HIV-infected patients with locoregionally advanced non-small cell lung cancer: benefit and tolerability of treatment in 2 cases

scientific article published on 17 September 2013

Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients

scientific article published in 2022

Correction to: High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer

scientific article published on 01 September 2018

Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma

scientific article

Correlation between the qualification for bevacizumab use and the survival of patients with non-small cell lung cancer harboring the epidermal growth factor receptor mutation: a retrospective analysis

scientific article published on 26 July 2019

Crucial role of treatment with palliative intent for a patient with advanced thymic carcinoma

scientific article published on 3 June 2014

Development of Hepatocellular Carcinoma During Nivolumab Treatment for Recurrent Non-Small Cell Lung Cancer: A Case Report

scientific article published on 01 April 2019

Eligibility for Bevacizumab as an Independent Prognostic Factor for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study ⬇️

scientific article published on March 26, 2013

Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma

scientific article published on 15 April 2016

Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing

scientific article published on 04 December 2018

Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014.

scientific article published on 19 October 2015

Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations.

scientific article

Harmonization study of antibodies and platforms for programmed death ligand 1 immunostaining in non-small cell lung cancer: does shuffling couples settle the troubles?

scientific article published on 01 July 2018

High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer

scientific article

High Serum Soluble CD27 Level Correlates with Poor Performance Status and Reduced Survival in Patients with Advanced Lung Cancer

scientific article published on 18 September 2019

High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer.

scientific article published on 5 December 2016

Immune checkpoint inhibitors: the next step for thymic carcinomas.

scientific article published on 25 January 2018

Immune-related pancreatitis secondary to nivolumab in a patient with recurrent lung adenocarcinoma: A case report.

scientific article

Impact of clinical features on the efficacy of osimertinib therapy in patients with T790M-positive non-small cell lung cancer and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors

scientific article published on 01 June 2019

Impact of prior antibiotic use on the efficacy of nivolumab for non-small cell lung cancer

scientific article published on 08 January 2019

Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy.

scientific article

Long-term survival following metachronous intratumoral hemorrhage in an HIV-infected patient with lung cancer.

scientific article published on 11 May 2010

Lung cancer patients harboring epidermal growth factor receptor mutation among those infected by human immunodeficiency virus

scientific article

Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review.

scientific article

Management of cardiac tamponade during nivolumab of lung cancer with intrapericardial bleomycin: case report

scientific article published on 07 February 2019

Management of non-small cell lung cancer harboring epidermal growth factor receptor mutations in the era of first-line osimertinib

scientific article published on 01 July 2019

Molecular and Morphological Profiling of Lung Cancer: A Foundation for "Next-Generation" Pathologists and Oncologists.

scientific article published on 29 April 2019

New histological classification and staging of thymic malignancies: ITMIG consensus statements and the 8th TNM staging system.

scientific article published in October 2017

Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1.

scientific article published on 24 August 2016

Osimertinib for advanced non-small cell lung cancer harboring EGFR mutation exon 20 T790M, acquired resistant mutation for first- or second-generation EGFR-TKI.

scientific article published on March 2017

Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment

scientific article published on 29 February 2016

Perspective on immune oncology with liquid biopsy, peripheral blood mononuclear cells, and microbiome with non-invasive biomarkers in cancer patients

scientific article published on 8 January 2018

Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604

scientific article

Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapy

scientific article published on 28 January 2016

Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202)

scientific article published on 01 August 2019

Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma

scientific article published on 19 August 2020

Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature.

scientific article

Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.

scientific article published on 22 March 2018

Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy

scientific article published on 20 August 2020

Prospective exosome-focused translational research for afatinib study of non-small cell lung cancer patients expressing EGFR (EXTRA study)

scientific article published on 08 December 2018

Radiographic Assessment of Objective Responses Using the ITMIG-Modified Criteria in Thymic Carcinoma

scientific article published on 15 July 2019

Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case report.

scientific article published on 20 March 2018

Response to "Immune-mediated cholangitis: is it always nivolumab's fault?"

scientific article

Response to cytotoxic chemotherapy in patients previously treated with palliative-intent chemotherapy for advanced thymic carcinoma.

scientific article

Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients

scientific article published on 01 August 2019

Retrospective analysis of survival in patients with leptomeningeal carcinomatosis from lung adenocarcinoma treated with erlotinib and gefitinib

scientific article published on 6 January 2017

Retrospective analysis of unknown primary cancers with malignant pleural effusion at initial diagnosis.

scientific article

S-1 is an active anticancer agent for advanced thymic carcinoma.

scientific article published on 15 October 2010

Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer

scientific article published on 05 May 2018

Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutations

scientific article

Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors

scientific article

The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer

scientific article published on 27 July 2020

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

scientific article published on 02 May 2019

The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases

scientific article published on 11 December 2019

The potency of curative-intent treatment for advanced thymic carcinoma.

scientific article published on 02 March 2014

Thymic Carcinoma With Endobronchial Metastasis: A Case Report

scientific article published on April 2017

Paulina is supported by:

About Paulina

Help